功能性多发性垂体腺瘤中的「诱饵病灶」:诊断陷阱与手术策略综述
该综述系统检索2000至2024年PubMed、Web of Science和Embase的英文病例报告,纳入24篇报告共35例多发性垂体腺瘤患者,并结合2例示例病例,提出按内分泌结局、影像特征和手术所见区分责任病灶与诱饵病灶。结果显示责任病灶在术前MRI上更不显眼且通常更小,43%(15/35)患者初次手术后未达生化缓解,其中相当比例与遗漏责任病灶有关。
要点
- 功能性多发性垂体腺瘤中,影像上占优势的病灶未必是激素责任病灶,需警惕诱饵病灶。
- 责任病灶在术前MRI上常更不显眼、体积更小,易被漏判。
- 43%(15/35)患者初次手术后未达生化缓解,识别诱饵病灶有助于改善手术规划与内分泌结局。
核心结论
- 识别诱饵病灶并与责任病灶区分,可能改善复杂多发性垂体腺瘤病例的手术规划与内分泌结局。
研究设计与样本
- 系统综述2000至2024年PubMed、Web of Science和Embase的英文多发性垂体腺瘤病例报告,纳入24篇报告共35例患者,并报告2例示例病例。
- 按结合内分泌结局、影像特征和手术所见制定的操作性定义,将病灶分为责任病灶或诱饵病灶。
主要发现
- 35例患者平均年龄40岁,男性12例、女性23例。
- 最常见临床表现为肢端肥大症(n=13,37%)和库欣综合征(n=11,31%)。
- 与诱饵病灶相比,责任病灶在术前MRI上更不显眼且通常更小。
- 43%(15/35)患者初次手术后未达生化缓解,相当比例病例报告遗漏责任病灶。
临床怎么用
- 对功能性多发性垂体腺瘤,术前应结合内分泌评估与影像判断责任病灶,避免仅凭影像优势病灶决定手术目标。
- 术中需有意识地寻找并处理可能更小、更不显眼的责任病灶,以降低术后生化未缓解风险。
局限性
- 证据来自病例报告的系统综述,样本量有限(35例),可能存在报告偏倚,结论需更大样本研究验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Multiple pituitary adenomas (MPA), particularly those involving functioning adenoma, represent a special subtype of pituitary adenomas that pose dual challenges in diagnosis and treatment. In this setting, the coexistence of hormonally active and silent lesions may result in a diagnostic pitfall when a radiologically dominant tumor does not correspond to the hormonally responsible lesion. This misleading lesion, often referred to as decoy lesion, can adversely influence surgical decision-making in patients with MPA. METHODS: We systematically reviewed English-language case reports of multiple pituitary adenomas published between 2000 and 2024 in PubMed, Web of Science, and Embase and present 2 illustrative cases. Lesions were classified as responsibility lesions or decoy lesions based on an operational definition incorporating endocrine outcomes, radiological features, and surgical findings. RESULTS: A total of 35 patients from 24 case reports met the inclusion criteria. The mean age was 40 years, with 12 male and 23 female patients. The most common clinical manifestations were acromegaly (n = 13, 37%) and Cushing's syndrome (n = 11, 31%). Our findings indicate that, compared with decoy lesions, responsibility lesions are less conspicuous on preoperative MRI and usually smaller in size. Overall, 43% of these patients (15/35) did not achieve biochemical remission after the initial surgery, with missed identification of the responsibility lesion reported in a substantial proportion of cases. CONCLUSIONS: Identifying decoy lesion and distinguishing it from responsibility lesion may improve surgical planning and endocrine outcomes in complex MPA cases.
引用
- Han B, Xuan P, Gao F, et al. Decoy Lesion in Functional Multiple Pituitary Adenomas: Literature Review and Illustrative Cases on Diagnostic Pitfalls and Surgical Strategies. World Neurosurg. 2026. PMID: 41651066. doi:10.1016/j.wneu.2026.124840
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。